Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 1
2008 1
2009 2
2010 4
2011 2
2012 1
2013 4
2014 2
2015 4
2016 3
2017 3
2019 2
2020 2
2021 2
2022 4
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
HLA-DR meets ERK.
Hertlein E, Byrd JC. Hertlein E, et al. Blood. 2010 Jun 24;115(25):5126-7. doi: 10.1182/blood-2010-03-270256. Blood. 2010. PMID: 20576816 Free article. No abstract available.
Signalling to drug resistance in CLL.
Hertlein E, Byrd JC. Hertlein E, et al. Best Pract Res Clin Haematol. 2010 Mar;23(1):121-31. doi: 10.1016/j.beha.2010.01.007. Best Pract Res Clin Haematol. 2010. PMID: 20620976 Review.
A FOXy target in B-cell survival.
Hertlein E. Hertlein E. Blood. 2014 Nov 27;124(23):3340-1. doi: 10.1182/blood-2014-10-605014. Blood. 2014. PMID: 25431475 Free article. No abstract available.
Significance of chromosome 2p gain in ibrutinib-treated chronic lymphocytic leukemia patients.
Miller CR, Huang Y, Ruppert AS, Labanowska J, Jaglowski SM, Maddocks KJ, Rogers KA, Bhat S, Kittai AS, Grever M, Lapalombella R, Abruzzo LV, Heerema NA, Byrd JC, Hertlein EK, Woyach JA. Miller CR, et al. Among authors: hertlein ek. Leukemia. 2021 Nov;35(11):3287-3290. doi: 10.1038/s41375-021-01237-x. Epub 2021 Apr 5. Leukemia. 2021. PMID: 33820961 Free PMC article. No abstract available.
Molecular, clinical, and prognostic implications of PTPN11 mutations in acute myeloid leukemia.
Fobare S, Kohlschmidt J, Ozer HG, Mrózek K, Nicolet D, Mims AS, Garzon R, Blachly JS, Orwick S, Carroll AJ, Stone RM, Wang ES, Kolitz JE, Powell BL, Oakes CC, Eisfeld AK, Hertlein E, Byrd JC. Fobare S, et al. Among authors: hertlein e. Blood Adv. 2022 Mar 8;6(5):1371-1380. doi: 10.1182/bloodadvances.2021006242. Blood Adv. 2022. PMID: 34847232 Free PMC article.
TP-0903 is active in models of drug-resistant acute myeloid leukemia.
Jeon JY, Buelow DR, Garrison DA, Niu M, Eisenmann ED, Huang KM, Zavorka Thomas ME, Weber RH, Whatcott CJ, Warner SL, Orwick SJ, Carmichael B, Stahl E, Brinton LT, Lapalombella R, Blachly JS, Hertlein E, Byrd JC, Bhatnagar B, Baker SD. Jeon JY, et al. Among authors: hertlein e. JCI Insight. 2020 Dec 3;5(23):e140169. doi: 10.1172/jci.insight.140169. JCI Insight. 2020. PMID: 33268594 Free PMC article.
RelA/p65 regulation of IkappaBbeta.
Hertlein E, Wang J, Ladner KJ, Bakkar N, Guttridge DC. Hertlein E, et al. Mol Cell Biol. 2005 Jun;25(12):4956-68. doi: 10.1128/MCB.25.12.4956-4968.2005. Mol Cell Biol. 2005. PMID: 15923614 Free PMC article.
Leukemic B Cell CTLA-4 Suppresses Costimulation of T Cells.
Do P, Beckwith KA, Cheney C, Tran M, Beaver L, Griffin BG, Mo X, Liu Y, Lapalombella R, Hertlein E, Muthusamy N, Byrd JC. Do P, et al. Among authors: hertlein e. J Immunol. 2019 May 1;202(9):2806-2816. doi: 10.4049/jimmunol.1801359. Epub 2019 Mar 25. J Immunol. 2019. PMID: 30910862 Free PMC article.
41 results